South Africa

An MSF vehicle in Rustenburg, on South Africa’s platinum mining belt, where our teams work with the health department to provide victims of sexual violence with medical and psychological care. September 2019. © Tadeu Andre/MSF

In South Africa, MSF continues to develop innovative strategies to prevent and treat HIV and tuberculosis (TB) and provide comprehensive care for victims of sexual violence.

In 2019, our large-scale community HIV/TB project in King Cetshwayo district, KwaZulu-Natal, run in collaboration with the Department of Health, became the first in South Africa to reach….

Read full article in International Activity Report 2019

related articles

Campagne de peintures murales pro-vaccination de MSF à Khayelitsha

South Africa

A step forward towards increased COVID-19 vaccine manufacturing capacity

MSF responds to the WHO's announcement that six countries - Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia - will receive technology from the COVID-19 mRNA technology transfer centre. It is encouraging to see that this centre is getting closer to developing and validating the world's first open access mRNA vaccine production platform.

Covid-19. Vaccins. Coronavirus. Campagne d'accès. Covax.

South Africa

Southern Africa needs the right COVID vaccines, at the right price – right now

MSF urges wealthy countries and pharma companies to immediately equitably distribute the right vaccines, at the right price, to low- and middle-income countries.

South Africa

UNAIDS update: the fight against HIV is far from over

770 000 people died of HIV worldwide in 2018 and yet the annual number of deaths due to AIDS has declined only minimally since 2014, a real concern for MSF.

A child vaccinated against measles gets marked in order to avoid confusion during a vaccination day on the island of Kassa, Guinea. © Markel Redondo

South Africa, Bangladesh, Greece, Guinea, Iraq, Democratic Republic of the Congo, Zimbabwe

A Sneak Peek into Eight MSF Operational Research Projects

In two video features, eight researchers explain how their work supports MSF projects in Guinea, Bangladesh, Zimbabwe, and beyond.

MSF South Africa HIV

South Africa

HIV project in Eshowe reaches 90-90-90 target one year ahead of 2020 deadline

MSF released findings from a follow-up survey of its community-based HIV/TB project in Eshowe, KwaZulu Natal. It shows that the project has achieved the UNAIDS targets of 90-90-90 one year ahead of the 2020 deadline.